EXCEED THE SPACE PROVIDED. Angiogenesis is essential for tumor growth and blocking this process is viewed as a valid tool for the control of cancer growth. We showed that in integrin _l-null mice tumor angiogenesis is reduced compared to that of wild type mice. This reduction is due to overexpression of matrix metaUoproteinases (MMPs) in the al-null and consequent generation of angiostatin (an inhibitor of endothelial cell growth) from plasminogen. Our findings, in contrast to the accepted role of MMPs being pro-tumorigenic, suggest that excess synthesis of MMPs may play opposite effects on tumor growth. On one hand, increased MMPs may promote cell migration and metastasis by inducing extracellular matrix degradation. On the other hand, increased MMPs may prevent tumor growth via angiostatin generation. We showed that inhibition of MMP expression in vivo leads to decreased synthesis of angiostatin and consequent increased tumor growth and vascularization. This observation, together with the disappointing results achieved by MMP inhibitors in the treatment of human cancers, suggests that MMP inhibitors used as anti-tumor drugs might in fact cause a paradoxical increase in tumor growth and angiogenesis by preventing the generation of inhibitors of endothelial cell growth. In addition, we also showed that integrin otl is directly involved in the control of cell proliferation suggesting that this receptor may play a synergistic role together with the MMP/angiostatin axis by directly regulating endothelial cell proliferation. The role of integrin o_1 and the MMP/angiostatin axis in tumor progression will be explored in the following aims. 1) Analyze in vivo i) the role of the MMP/angiostatin axis in the control of primary vs. metastatic human tumors, ii) whether MMP inhibitors can be successfully used in the prophylaxis of primary vs. metastatic cancers. II) Distinguish between a direct role of integrin c_l in the control of endothelial cell proliferation and the effect of MMPs or angiostatin by crossing the otl-null mice with the plasminogen- or MMP-null mice. III) Analyze in real time the effect of angiostatin and MMP inhibitors on tumor vascularization using the cutaneous window assay. These studies will help us to determine how stinaulation of the MMP/angiostatin axis can be used as a tool to inhibit specifically tumor vaseularization and growth. PERFORMANCE SITE ========================================Section End===========================================

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA094849-03S1
Application #
6994226
Study Section
Pathology B Study Section (PTHB)
Program Officer
Ogunbiyi, Peter
Project Start
2003-01-10
Project End
2007-12-31
Budget Start
2005-01-01
Budget End
2005-12-31
Support Year
3
Fiscal Year
2005
Total Cost
$43,413
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Zhang, Ming-Zhi; Xu, Jie; Yao, Bing et al. (2009) Inhibition of 11beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans. J Clin Invest 119:876-85
Yang, Shiling; Wei, Shouzou; Pozzi, Ambra et al. (2009) The arachidonic acid epoxygenase is a component of the signaling mechanisms responsible for VEGF-stimulated angiogenesis. Arch Biochem Biophys 489:82-91
Macias-Perez, Ines; Borza, Corina; Chen, Xiwu et al. (2008) Loss of integrin alpha1beta1 ameliorates Kras-induced lung cancer. Cancer Res 68:6127-35
Erdogan, Mete; Pozzi, Ambra; Bhowmick, Neil et al. (2008) Transforming growth factor-beta (TGF-beta) and TGF-beta-associated kinase 1 are required for R-Ras-mediated transformation of mammary epithelial cells. Cancer Res 68:6224-31
Abair, Tristin D; Bulus, Nada; Borza, Corina et al. (2008) Functional analysis of the cytoplasmic domain of the integrin {alpha}1 subunit in endothelial cells. Blood 112:3242-54
Macias-Perez, Ines M; Zent, Roy; Carmosino, Monica et al. (2008) Mouse EP3 alpha, beta, and gamma receptor variants reduce tumor cell proliferation and tumorigenesis in vivo. J Biol Chem 283:12538-45
Pozzi, Ambra; Jarad, George; Moeckel, Gilbert W et al. (2008) Beta1 integrin expression by podocytes is required to maintain glomerular structural integrity. Dev Biol 316:288-301
Cosgrove, Dominic; Meehan, Daniel T; Delimont, Duane et al. (2008) Integrin alpha1beta1 regulates matrix metalloproteinases via P38 mitogen-activated protein kinase in mesangial cells: implications for Alport syndrome. Am J Pathol 172:761-73
Borza, Corina M; Borza, Dorin-Bogdan; Pedchenko, Vadim et al. (2008) Human podocytes adhere to the KRGDS motif of the alpha3alpha4alpha5 collagen IV network. J Am Soc Nephrol 19:677-84
Erdogan, Mete; Pozzi, Ambra; Bhowmick, Neil et al. (2007) Signaling pathways regulating TC21-induced tumorigenesis. J Biol Chem 282:27713-20

Showing the most recent 10 out of 30 publications